🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Beriplex

Found 14 matching trials

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

N/A

This observational cohort study is designed to obtain product safety inform...

Status

Completed

Location

Study Site

Start Date

2014-04-24

Trial ID

NCT02319460

Treatments Being Tested

Kcentra®Plasma

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

PHASE3

The purpose of this study is to evaluate efficacy, safety and tolerance of ...

Status

Completed

Location

Study Site

Start Date

2008-06

Trial ID

NCT00708435

Treatments Being Tested

Beriplex® P/N (Kcentra)Fresh frozen plasma

Reversal of Dabigatran With Prothrombin Complex Concentrate

PHASE2

The purpose of this study is to investigate whether Prothrombin Complex Con...

Status

Unknown

Location

University Medical Centre

Start Date

2015-01

Trial ID

NCT02463591

Treatments Being Tested

Beriplex

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

PHASE3

The purpose of this study is to evaluate efficacy, safety and tolerance of ...

Status

Completed

Location

Study Site

Start Date

2009-02

Trial ID

NCT00803101

Treatments Being Tested

Beriplex® P/N (Kcentra)Fresh frozen plasma

Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass

N/A

The primary goal of this investigation is to determine the ability of recom...

Status

Completed

Location

Children's Healthcare of Atlanta

Start Date

2011-03

Trial ID

NCT01352143

Treatments Being Tested

Recombinant activated factor VII Prothrombin Complex Concentrate

A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation

PHASE1

This Phase 1 study consists of 2 parts. Part 1 will be an open-label, rando...

Status

Completed

Location

Quintiles

Start Date

2013-10

Trial ID

NCT02047565

Treatments Being Tested

60mg edoxaban 180mg edoxaban 50 IU/kg Beriplex P/N 25 IU/kg Beriplex P/N 10 IU/kg Beriplex P/N

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

PHASE3

To demonstrate that the efficacy of OCTAPLEX as a reversal agent in patient...

Status

Completed

Location

Octapharma Research Site

Start Date

2017-06-08

Trial ID

NCT02740335

Treatments Being Tested

Octaplex Beriplex P/N (Kcentra)

Prothrombin Complex Concentrate for Anticoagulant Reversal

PHASE3

Patients on oral anticoagulants need rapid reversal of the anticoagulant ef...

Status

Completed

Location

Clinical Trials Registration Coordinator

Start Date

2005-09

Trial ID

NCT00168077

Treatments Being Tested

Prothrombin Complex Concentrate

Strategy of Transfusion in Trauma Patients - STATA Trial

PHASE4

The purpose of this study is to compare two already validated methods for m...

Status

Completed

Location

Hospital das Clínicas FMUSP

Start Date

2014-07

Trial ID

NCT02416817

Treatments Being Tested

Blood Products only Point of Care guided

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

PHASE1

The purpose of this study is to assess the effect of two 4-Factor PCC formu...

Status

Completed

Location

Multiple Locations

Start Date

2014-02

Trial ID

NCT02074358

Treatments Being Tested

Apixaban Cofact (4-Factor PCC)Beriplex P/N (4-Factor PCC)Placebo (Saline solution)

Previous Next